Pipeline — registered trials by phase
One Week Aligner Evaluation
— · Malocclusion · Completed · est. 2018-11
Primer Aligner Study
— · Malocclusion · Completed · est. 2020-09
Class II Correction Study Using the Invisalign System
— · Malocclusion · Completed · est. 2021-11-23
The Use of Clear Aligners With Movement Enhancement Techniques
— · Malocclusion · Completed · est. 2018-12
Hyrax Vs. Invisalign Palatal Expander Clinical Study
— · Malocclusions, Narrow Maxilla, Narrow Maxillary Arch · Recruiting · est. 2025-11
Invisalign® System with Mandibular Advancement
— · Class II Malocclusion, Mandibular Advancement, Mandibular Retrognathism · Recruiting · est. 2026-12-31
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Align Technology is lead sponsor; 6 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-08-31Current report (material event)
- SCHEDULE 13G/A2026-08-12SCHEDULE 13G/A
- SCHEDULE 13G/A2026-08-12SCHEDULE 13G/A
- SCHEDULE 13G2026-08-06SCHEDULE 13G
- 10-Q2026-08-05Quarterly report
- 8-K2026-07-29Current report (material event)
- 8-K2026-07-29Current report (material event)
- 8-K2026-07-09Current report (material event)
- 8-K2026-06-22Current report (material event)
- SD2026-05-29SD
- 8-K2026-05-20Current report (material event)
- SCHEDULE 13G2026-05-14SCHEDULE 13G
- SCHEDULE 13G/A2026-05-14SCHEDULE 13G/A
- 10-Q2026-05-06Quarterly report
- 8-K2026-05-01Current report (material event)
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- 8-K2026-04-29Current report (material event)
- DEFA14A2026-04-17DEFA14A
- ARS2026-04-07Annual report to holders
- DEFA14A2026-04-07DEFA14A
- DEF 14A2026-04-07Proxy statement
- PRE 14A2026-03-27PRE 14A
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- 10-K2026-02-27Annual report
- 8-K2026-02-26Current report (material event)
- SCHEDULE 13G2026-02-13SCHEDULE 13G
- 8-K2026-02-04Current report (material event)
- SCHEDULE 13G/A2026-01-21SCHEDULE 13G/A
- 10-Q2025-11-05Quarterly report
- 8-K2025-10-29Current report (material event)
- 8-K2025-09-18Current report (material event)
- S-82025-08-06Employee stock plan
- 10-Q2025-08-06Quarterly report
- 8-K2025-08-05Current report (material event)
- 8-K2025-07-30Current report (material event)
- 8-K2025-07-02Current report (material event)
- SD2025-05-30SD
- 8-K2025-05-21Current report (material event)
- 10-Q2025-05-08Quarterly report
- 8-K2025-05-06Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.